A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy

AIDS

Volumn 13, Issue 13, 1999, Pages 1659-1667

  Saint Marc, Thierry ^c   Partisani, Maria ^d   Poizot Martin, Isabelle ^a   Bruno, Franck ^b   Rouviere, Olivier ^c   Lang, Jean Marie ^d   Gastaut, Jean Albert ^a   Touraine, Jean Louis ^d  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b Stat'Aids   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d NONE

Author keywords

Adverse drug reactions; HIV; Lipodystrophy; Stavudine

Indexed keywords

C PEPTIDE; CD4 ANTIGEN; CHOLESTEROL; FATTY ACID; FOLLITROPIN; GLUCOSE; HYDROCORTISONE; INSULIN; LUTEINIZING HORMONE; NUCLEOSIDE ANALOG; STAVUDINE; TESTOSTERONE; TRIACYLGLYCEROL; ZIDOVUDINE;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; CALORIC INTAKE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FRANCE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPEDANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; LIPODYSTROPHY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKINFOLD THICKNESS; SUBCUTANEOUS FAT; VIRUS LOAD;

ADIPOSE TISSUE; ADULT; AGED; BODY COMPOSITION; CROSS-SECTIONAL STUDIES; ENERGY INTAKE; FEMALE; GLUCOSE TOLERANCE TEST; HIV INFECTIONS; HIV WASTING SYNDROME; HUMANS; LIPIDS; LIPODYSTROPHY; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; RISK FACTORS; STAVUDINE; SYNDROME; ZIDOVUDINE;

EID: 0033391005     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199909100-00009     Document Type: Article

References (19)

1. Hammer SM, Squires KF, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997, 337:725-733.
2. Carpenter CQJ, Fischl MA, Rammer SM, et al. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the international AIDS society-USA panel. JAMA 1997, 277:1962-1969.
3. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998, 12:F51-F58.
4. Viraben R, Aquilina C. Indinavir-associated lipodystrophy. AIDS 1998, 12:F37-F39.
5. Carr A, Samaras K, Chisholm DJ, et al., Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancel 1998, 351:1881-1883.
6. Martinez F, Gatell J. Metabolic abnormalities and use of HIV-1 protease inhibitors. Lancet 1998, 352:821-822.
7. Suttmann U, Muller MJ, Ockenga J, et al. Malnutrition and immune dysfunction in patients infected with human immunodeficiency virus. Klin Wochenschr 1991, 69:156-162.
8. Ott M, Lembeke B, Fischer H, et al. Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr 1993, 57:15-19.
9. Kotler DP, Wang J, Piedrson R. Studies of body composition in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985, 42:1255-1265.
10. Kotler DP, Rosenbaum KB, Wang J, et al. Alterations in body fat distribution in HIV-infected men and women. XII Conference on AIDS. Geneva, July 1998 [abstract] 32376].
11. Boulier A, Fricker J, Thomasset AL, et al. Fat-free mass estimation by the two-electrode impedance method. Am J Clin Notr 1990, 52:581-585.
12. Pierson Jr RN, Wang J, Heymsfield SB, et al. Measuring body fat: calibrating the rulers. Intermethod comparisons in 389 normal caucasian subjects. Am J Physiol 1991, 261:E829-E834.
13. Durnin JGVA, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 4.81 men and women aged from 16 to 72 years. Br J Nutr 1974, 37:77-97.
14. Miller K, Jones F, Yanoversusky J, et al. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998, 351:871-875.
15. WHO. Diabetes mellitus: report of a WHO study group. World Health Organ Tech Rep Ser 1985, 727:9-17.
16. Intelligent Software Engineering. FoodPerfect. Nutritional analysis software. Victoria: Intelligent Software Engineering.
17. Carr A, Samaras K, Thorisdottir A, et al. Diagnosis and prediction of HIV protease inhibitor (MI)-induced lipodystrophy and impaired glucose tolerance, Sixth Conference on Retroviruses and Opportunistic Infection. Chicago, January-February 1999 [abstract 641].
18. Carr A, Thorisdottir A, Samaras K et al. Reversibility of protease inhibitor (PI) lipodystrophy syndrome on stopping Pis or switching to nelfinavir. Sixth Conference on Retroviruses and Opportunistic Infection. Chicago, January-February 1999 [abstract 668].
19. Saint-Marc T, Lourain JI. Truncal adiposity syndrome, hyper-insulinemia, endocrine and metabolic disorders in patients receiving HIV protease inhibitors. AIDS 1998, 12(Suppl 4):S54.